ClariVest Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.8M	Hold	43,911	–	–	0.29%	82
2024 Q2	$2.8M	Sell	43,911 -6,199	-12%	-$402K	0.29%	82
2024 Q1	$3.46M	Sell	50,110 -71	-0.1%	-$4.29K	0.36%	56
2023 Q4	$2.77M	Sell	50,181 -1,157	-2%	-$63.7K	0.15%	103
2023 Q3	$2.98M	Buy	51,338 +13,792	+37%	+$796K	0.16%	92
2023 Q2	$2.02M	Buy	+37,546	New	+$1.66M	0.1%	130
2022 Q2	–	Sell	-18,643	Closed	-$524K	–	687
2022 Q1	$524K	Sell	18,643 -2,953	-14%	-$110K	0.02%	379
2021 Q4	$995K	Buy	21,596 +21,553	+50,123%	+$926K	0.03%	319
2021 Q3	$1K	Buy	+43	New	+$1.34K	﹤0.01%	662
2015 Q2	–	Sell	-40,550	Closed	-$2.54M	–	605
2015 Q1	$2.54M	Buy	40,550 +2,026	+5%	+$123K	0.08%	158
2014 Q4	$2.17M	Sell	38,524 -6,477	-14%	-$286K	0.08%	150
2014 Q3	$1.27M	Sell	45,001 -35	-0.1%	-$1.05K	0.05%	217
2014 Q2	$1.55M	Sell	45,036 -11,578	-20%	-$363K	0.06%	200
2014 Q1	$1.77M	Buy	+56,614	New	+$1.5M	0.07%	177